£1.72m
+33%vs Mar 2024Active11024723Private limited companyManchester
ENDOCARE DIAGNOSTICS LTD
A80/10001
Summary
ENDOCARE DIAGNOSTICS LTD is an active private limited company (company number 11024723) incorporated on 20 October 2017, registered in Manchester. Its registered activity is general medical practice activities (SIC 86210). Latest small accounts cover the period ending 31 March 2025, showing net assets of £1.72m and cash of £59k, with 11 employees on average. Net assets rose 33% on the prior period (£1.29m).
Peer position · net assets
By net assets it sits in the top quarter of 1,687 comparable companies in Manchester (median £16k, upper quartile £82k).
02
Key dates
- Incorporated
- 20 October 20179 yrs ago
- Next accounts due
- 31 December 2026in 70 days
- Confirmation statement due
- 3 November 2026in 12 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 86210
- General medical practice activities
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
04
Financials
£59k
+395%vs Mar 2024Not reported
11
−21%vs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £1.72m | £59k | £1.30m | — | — | — | 11 |
| 31 March 2024 | £1.29m | £12k | £1.08m | — | — | — | 14 |
Cash per employee£5,320Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
05
Firmoscan score
80 / 100 · grade A
| 50 | Starting scoreEvery scored company starts here |
| +10 | Positive net assetsNet assets £1,722,384 at 2025-03-31 |
| +8 | Net assets growing+33.3% vs prior period |
| +4 | Cash reservesCash £58,516 |
| +8 | EstablishedIncorporated 2017-10-20 (9 years) |
| 80 | Score, grade A |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
06
Ownership and control
- Dr Atta Mohammed Abbasi
- has significant influence or control
- Mr Bashir Rameh
- has significant influence or control
- Dr Waqar Ahmed
- has significant influence or control
- Dr Abdelrahilm Ahmed Dawood
- has significant influence or control
- Dr Saifudin Khalid
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Next accounts duein 70 days
- Confirmation statement duein 12 days
- Accounts period endNet assets £1.72m · small accounts
- Accounts period endNet assets £1.29m · small accounts
- Incorporated
08
Similar companies in Manchester
- REDBURN LOCUMS LIMITEDStockport · inc. Oct 2017
- MEDIASSIST LTDManchester · inc. Oct 2017
- E NIXON CONSULTANT LIMITEDSalford · inc. Oct 2017
- BLUEDOT MEDICAL SERVICES LTDStockport · inc. Oct 2017
- TOTALLY AESTHETICS TRAINING LIMITEDRamsbottom · inc. Oct 2017
- DOCTOR&MEDICS LIMITEDManchester · inc. Nov 2017
All companies incorporated on 20 October 2017 · in Oct 2017.
09
Reminders for ENDOCARE DIAGNOSTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.